Pharmacology Flashcards
sympathetic nervous system acts on __ receptors mediated by __ causing ___
B1 adrenoceptors
adrenaline and noradrenaline
increase in heart rate and contractility
sympathetic nerves innervate nodal and myocardial cells true/false
true
how do beta-adrenoceptors increase heart rate and contractility
activate G protein coupled receptors - activates adenylyl cyclase - increases cAMP - increases number of L-type channels - triggers release of calcium from SR
increase in heart rate is known as
positive chronotropic effect
increase in heart contractility is known as
positive inotropic effect
parasympathetic nervous system acts on __ mediated by __ causing ___
M2 muscarinic cholinoceptors
mediated by ACh
decrease in heart rate
parasympathetic nerves innervate nodal and myocardial cells true/false
false only on nodal cells - therefore only has effect on heart rate but not contractility
how does parasympathetic nerves decrease heart rate in nodal cells
when M2 binds to ACh making G protein - cAMP is reduced and potassium channels open decreasing contraction slope
what are the stages occurring for cardiac muscle contraction to occur
Ca L-type channels open during phase 2 - influx of Ca - triggers release of Ca from SR (CICR) - Ca binds to troponin C moving tropomyosin causing contraction
describe calcium induced calcium release
increasing the intracellular concentration of calcium causes further increase in its concentration from the sarcoplasmic reticulum
how does relaxation of cardiac muscle occur
repolarisation in phase 3 and 4 closes L-type channels. Ca influx stops and Ca dissociates from troponin C causing relaxation of muscle
what is the purpose of vagal manoeuvres
suppress conduction through the AVN - therefore decreasing heart rate
what are vagal manoeuvres used for
SVTs such as atrial fibrillation and atrial flutter
what is the funny current mediated by
HCN channels
which drug selectively blocks the HCN channel
ivabradine - decreasing slope on pacemaker potential
which conditions is ivabradine used for
angina - lowers oxygen requirements
which two areas can drugs act on to alter heart rate and contractility
beta-adrenoceptors
muscarinic receptors
what is the effect of B1 adrenoceptor agonists
activated adenylyl cyclase increasing cAMP which increases heart rate
name two examples of B-adrenoceptor agonists and their uses
dobutamine - IV for heart failure
adrenaline - cardiac arrest and anaphylaxis
what is the effect of beta-blockers
either selectively or non-selectively block beta-adrenoceptor slowing conduction through AVN reducing heart rate/oxygen requirement
name a non-selective beta-blocker and what does it act on
propanolol acting on B1 and B2 adrenoceptors
name some selective beta-blockers
atenolol, bisoprolol, metoprolol
what are the clinical uses of beta-blockers
angina
arrhythmias - esp AF
heart failure - start low and go slow as reduces sympathetic drive
(hypertension if extreme)
what are the side effects of beta-blockers
bradycardia can trigger bronchospasm esp in asthmatics fatigue hypoglycaemia can aggravate heart failure cold extremities
what is the effect of muscarinic ACh receptor antagonists
block parasympathetic action therefore increase heart rate
name two drugs that are muscarinic receptor antagonists
atropine
digoxin
what is the clinical use of atropine
used for extreme bradycardia following an MI
what is the clinical use of digoxin
treatment of heart failure as increases contractility
what are the side effects of digoxin
can cause heart block
arrhythmias
GI disturbances
disturbance to colour vision
what are the classifications of drugs that have direct effect on vasculature and BP
organic nitrates
calcium channel blockers
ACEi and ARBs
how does smooth muscle contraction occur in vasculature
Ca through L-type channels activates MLCK causing contraction
how does relaxation occur in smooth muscle vasculature
myosin light chain phosphatase activated by protein kinase G causes relaxation of smooth muscle
what is the action of organic nitrates
organic nitrates metabolised into nitric oxide causing venorelaxation and arteriolar dilatation causing increased coronary blood flow